Found: 8
Select item for more details and to access through your institution.
Large Extracellular Vesicle Characterization and Association with Circulating Tumor Cells in Metastatic Castrate Resistant Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1056, doi. 10.3390/cancers13051056
- By:
- Publication type:
- Article
Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.
- Published in:
- Science Signaling, 2017, v. 10, n. 480, p. 1, doi. 10.1126/scisignal.aam7479
- By:
- Publication type:
- Article
Targeting Poly(ADP-Ribose) Polymerase and the c-Myb--Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer.
- Published in:
- Science Signaling, 2014, v. 7, n. 326, p. 1, doi. 10.1126/scisignal.2005070
- By:
- Publication type:
- Article
Epigenetics in Prostate Cancer.
- Published in:
- Prostate Cancer (20903111), 2011, p. 1, doi. 10.1155/2011/580318
- By:
- Publication type:
- Article
Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00069
- By:
- Publication type:
- Article
Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0048787
- By:
- Publication type:
- Article
Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium – an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 812, doi. 10.1007/s10637-020-01038-6
- By:
- Publication type:
- Article
Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 9, p. e2122998, doi. 10.1001/jamanetworkopen.2021.22998
- By:
- Publication type:
- Article